W.R. Bezwoda

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda et al. · Journal of Clinical Oncology · 1999 · 506 citations

The non-immune inflammatory response: Serial changes in plasma iron, iron-binding capacity, lactoferrin, ferritin and C-reactive protein

Roy Baynes, W.R. Bezwoda, T. H. Bothwell et al. · Scandinavian Journal of Clinical and Laboratory Investigation · 1986 · 130 citations

Iron Metabolism, Immunology, White Cell Count +20

Hematologic, iron-related, and acute-phase protein responses to sustained strenuous exercise

C. B. Taylor, G. G. Rogers, Craig A. Goodman et al. · Journal of Applied Physiology · 1987 · 123 citations

Physical Activity, Iron Metabolism, Transferrin Saturation +16

Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer

Lesley Seymour, D. Dajee, W.R. Bezwoda · Breast Cancer Research and Treatment · 1993 · 99 citations

Advanced Breast Cancer, Breast Oncology, Derived-growth Factor +9

Platelet-derived growth factor (PDGF) in plasma of breast cancer patients: Correlation with stage and rate of progression

Samuel Ariad, L. Seymour, W.R. Bezwoda · Breast Cancer Research and Treatment · 1991 · 98 citations

Thrombopoiesis, Breast Oncology, Blood Platelet +9